Chemed (NYSE:CHE) reported quarterly earnings of $4.74 per share which beat the analyst consensus estimate of $4.65 by 1.94 percent. This is a 6.32 percent decrease over earnings of $5.06 per share from the same period last year.
Carter’s Q4 Adj. EPS $2.31 Beats $2.06 Estimate, Sales $1.10B Beat $1.03B Estimate
Carter's (NYSE:CRI) reported quarterly earnings of $2.31 per share which beat the analyst consensus estimate of $2.06 by 12.14 percent. This is a 6.1 percent decrease over earnings of $2.46 per share from the same period
